ampc beta lactamases & in vivo development of resistance - dr sumit rai
Published 2 years ago • 4.4K plays • Length 48:15Download video MP4
Download video MP3
Similar videos
-
26:44
ampc beta lactamases: what should we know
-
42:11
clinical utility of mics: microcon 2022
-
0:10
sumit rai super video editing
-
33:51
don’t be afraid to experiment | sumit rai | tbcy
-
1:59
investigating the mechanisms of initial & acquired resistance to bcma car-t therapy in myeloma
-
5:40
current concepts and future developments in t-cell-based immunotherapy of aml
-
1:14
phase i study of abbv-383, a bcma×cd3 bispecific antibody, in r/r myeloma
-
2:26
aims & activity of the brazilian society of bone marrow transplantation and cellular therapy (sbtmo)
-
53:30
paisa vaisa - the edelweiss tokio life insurance special feat. sumit rai #318
-
7:49
idecabtagene vicleucel, a bcma-directed car t cell therapy, in rrmm: updated karmma results
-
6:34
bcma-cd38 bispecific car-t cells in r/r mm
-
2:01
glycolysis and mitochondrial respiration in lymphocytes: analysis | protocol preview
-
1:31
integrating bcma-directed bispecifics and car-t into the myeloma treatment landscape
-
4:10
overcoming the limits: bringing car t-cell therapy to the masses
-
5:46
where in the treatment sequence should car t-cells be used for myeloma?
-
51:47
sumit rai - ceo, chairman, and founder of cancer check labs | ep. 11
-
1:05
reprogramming leukemia cells into apcs as a novel therapeutic strategy for b-all